83 related articles for article (PubMed ID: 6421295)
1. [Bioavailability of glycerol trinitrate (nitroglycerin) from an ointment preparation].
Gielsdorf W; Schlegel E; Settlage JA; Jaeger H; Fink E
Arzneimittelforschung; 1983; 33(12):1677-9. PubMed ID: 6421295
[TBL] [Abstract][Full Text] [Related]
2. Glycerol trinitrate (nitroglycerin) plasma concentrations achieved after application of transdermal therapeutic systems to healthy volunteers.
Gerardin A; Gaudry D; Moppert J; Theobald W; Fankhauser P
Arzneimittelforschung; 1985; 35(2):530-2. PubMed ID: 3922382
[TBL] [Abstract][Full Text] [Related]
3. Studies of the bioavailability of nitroglycerin from a transdermal therapeutic system (Nitroderm TTS).
Imhof PR; Vuillemin T; Gérardin A; Racine A; Müller P; Follath F
Eur J Clin Pharmacol; 1984; 27(1):7-12. PubMed ID: 6436032
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacokinetics and relative bioavailability of a nitroglycerin ointment formulation (author's transl)].
Maier-Lenz H; Ringwelski L; Windorfer A
Arzneimittelforschung; 1980; 30(2):320-4. PubMed ID: 6769443
[TBL] [Abstract][Full Text] [Related]
5. Bioequivalence evaluation of two glyceryl trinitrate patches after 12-h usage in healthy volunteers.
Hutt V; Sauter K; Pabst G; Bonn R; Fritschi E
Arzneimittelforschung; 1994 Dec; 44(12):1313-6. PubMed ID: 7848349
[TBL] [Abstract][Full Text] [Related]
6. Systemic levels of glyceryl trinitrate following topical application to the anoderm do not correlate with the measured reduction in anal pressure.
Jonas M; Barrett DA; Shaw PN; Scholefield JH
Br J Surg; 2001 Dec; 88(12):1613-6. PubMed ID: 11736974
[TBL] [Abstract][Full Text] [Related]
7. Bioequivalence evaluation of the metabolites 1,2 and 1,3-glyceryl dinitrate of two different glyceryl trinitrate patches after 12-h usage in healthy volunteers.
Hutt V; Sauter K; Pabst G; Bonn R; Fritschi E
Arzneimittelforschung; 1994 Dec; 44(12):1317-21. PubMed ID: 7848350
[TBL] [Abstract][Full Text] [Related]
8. Studies on the bioavailability of glyceryl trinitrate after sublingual administration of spray and tablet.
Jensen KM; Mikkelsen S
Arzneimittelforschung; 1997 Jun; 47(6):716-8. PubMed ID: 9239449
[TBL] [Abstract][Full Text] [Related]
9. Plasma concentrations of glyceryl trinitrate and its dinitrate metabolites after sublingual administration to volunteers. Simultaneous determination of glyceryl trinitrate and its dinitrate metabolites.
Jensen KM; Dahl JB
Arzneimittelforschung; 1994 Aug; 44(8):951-3. PubMed ID: 7945539
[TBL] [Abstract][Full Text] [Related]
10. [Biologic availability and hemodynamic actions following administration of sublingual glycerol trinitrate. A new delivery system].
Huber T; Merz PG; Harder S
Arzneimittelforschung; 1991 Jul; 41(7):715-8. PubMed ID: 1772460
[TBL] [Abstract][Full Text] [Related]
11. Bioaequivalence of sublingual glycerol trinitrate. Bioavailability and haemodynamic effects after application of a fluorochlorohydrocarbons-dependent spray and a new pumping system.
Huber T; Merz PG; Harder S; Rietbrock N
Arzneimittelforschung; 1990 Dec; 40(12):1319-22. PubMed ID: 2128865
[TBL] [Abstract][Full Text] [Related]
12. [The effect on biologic availability of the choice of infusion material in nitroglycerin therapy].
Cawello W; Bonn R
Arzneimittelforschung; 1983; 33(4):595-7. PubMed ID: 6409129
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and bioavailability of pentaerithrityl tetranitrate and two of its metabolites.
Weber W; Michaelis K; Luckow V; Kuntze U; Stalleicken D
Arzneimittelforschung; 1995 Jul; 45(7):781-4. PubMed ID: 8573222
[TBL] [Abstract][Full Text] [Related]
14. [Biological availability of glycerol trinitrate after sublingual administration].
Rietbrock N; Herling C; Muck B
Arzneimittelforschung; 1989 Feb; 39(2):267-9. PubMed ID: 2499342
[TBL] [Abstract][Full Text] [Related]
15. The effect of glyceryl trinitrate ointment on posthemorrhoidectomy pain and wound healing: results of a randomized, double-blind, placebo-controlled study.
Karanlik H; Akturk R; Camlica H; Asoglu O
Dis Colon Rectum; 2009 Feb; 52(2):280-5. PubMed ID: 19279424
[TBL] [Abstract][Full Text] [Related]
16. Tolerance development and arterial and venous tissue-/plasma levels of glyceryl trinitrate and glyceryl dinitrate in patients treated with nitroglycerin infusion.
Torfgård KE; Svedjeholm R; Håkansson E; Ahlner J
Arzneimittelforschung; 1995 Sep; 45(9):963-6. PubMed ID: 7488313
[TBL] [Abstract][Full Text] [Related]
17. Absolute bioavailability of glyceryl trinitrate from a transdermal system, assessed by digital plethysmography.
Isenschmid M; Müller M; Bührer M; Vorkauf H; Bircher J
Int J Clin Pharmacol Ther Toxicol; 1985 Jul; 23(7):345-51. PubMed ID: 3928505
[TBL] [Abstract][Full Text] [Related]
18. Relative bioavailability of two spray formulations of nitroglycerin.
Sanders SW; Michaelis K; Maurette JM; Jaeger H
J Pharm Sci; 1986 Mar; 75(3):244-6. PubMed ID: 3084758
[TBL] [Abstract][Full Text] [Related]
19. [Therapeutic possibilities of sympathoadrenergic reactions during general anesthesia using sublingual application of glycerol trinitrate].
Olthoff D; Vetter B; Lüdecke F; Deutrich C
Anaesthesiol Reanim; 1992; 17(1):27-38. PubMed ID: 1642741
[TBL] [Abstract][Full Text] [Related]
20. Influence of the method of application on pharmacokinetics of nitroglycerin from ointment in humans.
Sved S; McLean WM; McGilveray IJ
J Pharm Sci; 1981 Dec; 70(12):1368-9. PubMed ID: 6798193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
